Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Health and Healthcare

Merck : MRK

All Merck Articles

1079 Articles

Chris Lange | Sep 13, 2016 at 7:25 AM EDT

Major Pharma Continues to See Significant Drop in Short Interest

The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Sep 7, 2016 at 4:01 PM EDT

Wal-Mart, Home Depot Weigh on DJIA Wednesday

September 7, 2016: Markets opened mixed Wednesday following largely unmemorable sessions overseas. European markets await a policy statement from the…

Chris Lange | Aug 25, 2016 at 8:45 AM EDT

Major Pharma Short Interest Faces Significant Drop

The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Aug 24, 2016 at 4:01 PM EDT

Merck, UnitedHealth Sink DJIA Wednesday

August 24, 2016: Markets opened lower Wednesday and only the Nasdaq Composite made even a brief visit to positive territory…

Jon C. Ogg | Aug 18, 2016 at 12:50 PM EDT

How Much Medivation Can Really Fetch in a Buyout

Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have…

Jon C. Ogg | Aug 15, 2016 at 1:05 PM EDT

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for…

Chris Lange | Aug 10, 2016 at 9:05 AM EDT

Major Pharma Short Interest Slides

The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Jon C. Ogg | Aug 10, 2016 at 8:05 AM EDT

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

The short interest data for the July 29 settlement date are out and it almost feels like short sellers are…

Paul Ausick | Aug 9, 2016 at 4:01 PM EDT

Amex, DuPont Drag on DJIA Tuesday

August 9, 2016: Markets opened higher again Tuesday following the lead of Asian and European exchanges. The productivity report cooled…

Paul Ausick | Aug 8, 2016 at 4:01 PM EDT

Healthcare Stocks Sink DJIA on Monday

August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red…

Jon C. Ogg | Aug 8, 2016 at 12:45 PM EDT

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise…

Paul Ausick | Aug 5, 2016 at 4:01 PM EDT

Merck Dominates DJIA Boost Friday

August 5, 2016: Markets opened higher Friday following the report of 255,000 new U.S. jobs added in July. The financial…

Chris Lange | Aug 5, 2016 at 10:35 AM EDT

Why Bristol-Myers Failure Is a Huge Win for Merck

Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was…

Paul Ausick | Jul 29, 2016 at 8:20 AM EDT

Merck Raises EPS Outlook After Q2 Earnings

Merck reported better-than-expected second-quarter 2016 results before markets opened Friday morning.

Chris Lange | Jul 27, 2016 at 8:25 AM EDT

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…

1 … 34 35 36 37 38 … 72

Merck : MRK

All Merck Articles

Major Pharma Continues to See Significant Drop in Short Interest

Wal-Mart, Home Depot Weigh on DJIA Wednesday

Major Pharma Short Interest Faces Significant Drop

Merck, UnitedHealth Sink DJIA Wednesday

How Much Medivation Can Really Fetch in a Buyout

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Major Pharma Short Interest Slides

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

Amex, DuPont Drag on DJIA Tuesday

Healthcare Stocks Sink DJIA on Monday

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Merck Dominates DJIA Boost Friday

Why Bristol-Myers Failure Is a Huge Win for Merck

Merck Raises EPS Outlook After Q2 Earnings

Short Sellers Get Selective on Major Pharma

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

Investors Are Ditching the Magnificent 7 For a New Group of Stocks: The MANGOS

1 Plain-As-Day Dividend King to Buy and Never Sell That Has Paid a Continuous Dividend Since 1891

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

Investors Are Ditching the Magnificent 7 For a New Group of Stocks: The MANGOS

1 Plain-As-Day Dividend King to Buy and Never Sell That Has Paid a Continuous Dividend Since 1891

Merck : MRK

All Merck Articles

Major Pharma Continues to See Significant Drop in Short Interest

Wal-Mart, Home Depot Weigh on DJIA Wednesday

Major Pharma Short Interest Faces Significant Drop

Merck, UnitedHealth Sink DJIA Wednesday

How Much Medivation Can Really Fetch in a Buyout

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Major Pharma Short Interest Slides

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

Amex, DuPont Drag on DJIA Tuesday

Healthcare Stocks Sink DJIA on Monday

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Merck Dominates DJIA Boost Friday

Why Bristol-Myers Failure Is a Huge Win for Merck

Merck Raises EPS Outlook After Q2 Earnings

Short Sellers Get Selective on Major Pharma

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

Investors Are Ditching the Magnificent 7 For a New Group of Stocks: The MANGOS

1 Plain-As-Day Dividend King to Buy and Never Sell That Has Paid a Continuous Dividend Since 1891

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

Featured Reads

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge